CLINICAL AND MOLECULAR BIOMARKERS IN THE MANAGEMENT OF GLAUCOMA SMOKERS
Por:
Pinazo-Duran, M, Escriva-Pastor, E, Zanon-Moreno, V, Sanz-Gonzalez, S, Medina, J, Torregrosa, S and del Castillo, J
Publicada:
1 jun 2020
Resumen:
Filiaciones:
:
Ophthalm Res Unit Santiago Grisolia FISABIO, Ophthalm Res, Valencia, Spain
Univ Valencia, Surg Ophthalmol Dept, Fac Med, Valencia, Spain
:
Ophthalm Res Unit Santiago Grisolia FISABIO, Ophthalm Res, Valencia, Spain
:
Ophthalm Res Unit Santiago Grisolia FISABIO, Ophthalm Res, Valencia, Spain
Int Univ, Prevent Med & Publ Hlth, Valencia, Spain
:
Ophthalm Res Unit Santiago Grisolia FISABIO, Ophthalm Res, Valencia, Spain
Univ Valencia, Surg Ophthalmol Dept, Fac Med, Valencia, Spain
Medina, J:
Hosp Morales Meseguer, Ophthalmol, Murcia, Spain
Univ Murcia, Ophthalmol, Murcia, Spain
Torregrosa, S:
Hosp Punta Europa, Ophthalmol, Cadiz, Spain
del Castillo, J:
Hosp Jerez, Ophthalmol, Cadiz, Spain
Univ Cadiz, Surg Ophthalmol, Fac Med, Cadiz, Spain
|